Status:
UNKNOWN
Study of High Risk Non Invasive Prenatal Test Population
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Trisomy 21
Eligibility:
FEMALE
18+ years
Brief Summary
The investigator want to study the population of high risk (over 1/50) of Trisomy 21. According to french guidelines, these patients needs to have a invasive test (such as amniocentesis) but some pat...
Eligibility Criteria
Inclusion
- Prenatal screening of Trisomy 21 \> 1/50 (high risk population)
Exclusion
- No exclusion criteria
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04737070
Start Date
February 1 2021
End Date
July 1 2021
Last Update
February 3 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.